The Patent Finder

Procept Biorobotics Corporation

61 patents currently held · Updated Nov 16, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

1
Ending by 2030
Jan 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 11 to 18, 2026 · next Dec 11
  • 1 fee due Jan 9, 2027
    The maintenance fee for Cancer Treatment Apparatus (US 10,342,993) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
  • 2 fees due Feb 6 to 28, 2027 · next Feb 6
  • 1 fee due Mar 12, 2027
    The maintenance fee for Stiff Sheath for Imaging Probe (US 11,751,846) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
  • 2 fees due Apr 3 to 22, 2027 · next Apr 3
  • 4 fees due Jul 2 to 23, 2027 · next Jul 2
  • 1 fee due Sep 17, 2027
    The maintenance fee for Gene Analysis and Generation of Stem Cell Methods and Apparatus (US 10,588,609) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
  • 1 fee due Oct 23, 2027
    The maintenance fee for Artificial Intelligence for Robotic Surgery (US 11,963,729) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,321,931Minimally Invasive Methods for Multi-Fluid Tissue Ablation
In force
 · High confidence
In forceHigh confidence
US 9,364,251Automated Image-Guided Tissue Resection and Treatment
In force
 · High confidence
In forceHigh confidence
US 9,510,852Automated Image-Guided Tissue Resection and Treatment
In force
 · Medium confidence
In forceMedium confidence
US 9,668,764Automated Image-Guided Tissue Resection and Treatment
In force
 · High confidence
In forceHigh confidence
US 10,653,438Automated Image-Guided Tissue Resection and Treatment
In force
 · High confidence
In forceHigh confidence
US 11,464,536Automated Image-Guided Tissue Resection and Treatment
In force
 · High confidence
In forceHigh confidence
US 12,440,235Automated Image-Guided Tissue Resection and Treatment
In force
 · High confidence
In forceHigh confidence
US 11,337,719Water Enucleation of the Prostate
In force
 · High confidence
In forceHigh confidence
US 12,053,201Water Enucleation of the Prostate
In force
 · High confidence
In forceHigh confidence
US 11,737,776Automated Image-Guided Tissue Resection and Treatment
In force
 · High confidence
In forceHigh confidence
10 of 61 patents shown.
Pro members see all 61.
Pro members: see all 61 patents
Also on record, not counted in the 61: 3 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

25 pending · 2 abandoned · 2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited